Knowledge Mapping and Emerging Trends of Ferroptosis in Ischemia Reperfusion Injury Research: A Bibliometric Analysis (2013-2022)

Overview

Journal Heliyon

Specialty Social Sciences

Date 2023 Sep 28

PMID 37767486

Authors

Nianzhe Sun

Yixuan Xing

Junjie Jiang

Panfeng Wu

Liming Qing

Juyu Tang

Affiliations

Soon will be listed here.

Abstract

Objective: Ischemia/reperfusion (I/R) injury is an inevitable dilemma when previously ischemic multiple organs and tissues are returned to a state of blood flow, with confirming a critical role of ferroptosis in molecular, pathway mechanisms, subcellular structure. Discovering the potential relationship may provide useful approaches for the clinical treatment and prognosis of the pathophysiological status of IRI. Therefore, a comprehensive visualization and scientometric analysis were conducted to systematically summarize and discuss the "ferroptosis in ischemia reperfusion injury" research to demonstrate directions for scholars in this field.

Methods: We retrieved all publications focusing on I/R injury and ferroptosis from the Web of Science Core Collection (WoSCC), published from 2013 to October 2022. Next, scientometric analysis of different items was performed using various bibliometrics softwares to explore the annual trends, countries/regions, institutions, journals, authors and their multi-dimensional relationship pointing to current hotspots and future advancement in this field.

Results: We included a total of 421 English articles in set timespan. The number of publications increased steadily annually. China produced the highest number of publications, followed by the United States. Most publications were from Central South University, followed by Sichuan University and Wuhan University. The most authoritative academic journal was Oxidative Medicine and Cellular Longevity. Cell occupied the first rank of co-cited journal list. Andreas Linkermann and Scott J Dixon may have the highest influence in this intersected field with the highest number of citations and co-cited references respectively. The essential biological reactions such as oxidative stress response, lipid peroxidation metabolism, anti-inflammmatory and pro-inflammatory procedure, and related molecular pathways were knowledge base and current hotspots. Molecules pathways exploration, effective inhibition of I/R injury and promising strategy of improving allografts may become future trends and focuses.

Conclusions: Research on ferroptosis in I/R injury had aroused great interest recently. This first bibliometric study comprehensively analyzed the research landscape of ferroptosis and I/R injury, and also provided a reliable reference for related scholars to facilitate further advancement in this field.

Citing Articles

Knowledge mapping of ferroptosis in Parkinson's disease: a bibliometric analysis: 2012-2023.

Li J, Wang Y, Huang J, Gong D Front Aging Neurosci. 2024; 16:1433325.

PMID: 39280701 PMC: 11401074. DOI: 10.3389/fnagi.2024.1433325.

References

Kaiser W, Sridharan H, Huang C, Mandal P, Upton J, Gough P . Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL. J Biol Chem. 2013; 288(43):31268-79. PMC: 3829437. DOI: 10.1074/jbc.M113.462341. View

Feng Y, Ye W, Tian W, Meng J, Zhang M, Sun Y . Old targets, new strategy: Apigenin-7-O-β-d-(-6″-p-coumaroyl)-glucopyranoside prevents endothelial ferroptosis and alleviates intestinal ischemia-reperfusion injury through HO-1 and MAO-B inhibition. Free Radic Biol Med. 2022; 184:74-88. DOI: 10.1016/j.freeradbiomed.2022.03.033. View

Friedmann Angeli J, Schneider M, Proneth B, Tyurina Y, Tyurin V, Hammond V . Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol. 2014; 16(12):1180-91. PMC: 4894846. DOI: 10.1038/ncb3064. View

Speer R, Karuppagounder S, Basso M, Sleiman S, Kumar A, Brand D . Hypoxia-inducible factor prolyl hydroxylases as targets for neuroprotection by "antioxidant" metal chelators: From ferroptosis to stroke. Free Radic Biol Med. 2013; 62:26-36. PMC: 4327984. DOI: 10.1016/j.freeradbiomed.2013.01.026. View

Chen L, Hambright W, Na R, Ran Q . Ablation of the Ferroptosis Inhibitor Glutathione Peroxidase 4 in Neurons Results in Rapid Motor Neuron Degeneration and Paralysis. J Biol Chem. 2015; 290(47):28097-28106. PMC: 4653669. DOI: 10.1074/jbc.M115.680090. View

Su L, Jiang X, Yang C, Zhang J, Chen B, Li Y . Pannexin 1 mediates ferroptosis that contributes to renal ischemia/reperfusion injury. J Biol Chem. 2019; 294(50):19395-19404. PMC: 6916502. DOI: 10.1074/jbc.RA119.010949. View

Miao M, Han Y, Wang Y, Yang Y, Zhu R, Sun M . The research landscape of ferroptosis in the brain: A bibliometric analysis. Front Pharmacol. 2022; 13:1014550. PMC: 9622939. DOI: 10.3389/fphar.2022.1014550. View

Wang Y, Dong Z, Zhang Z, Wang Y, Yang K, Li X . Postconditioning with Irisin Attenuates Lung Ischemia/Reperfusion Injury by Suppressing Ferroptosis via Induction of the Nrf2/HO-1 Signal Axis. Oxid Med Cell Longev. 2022; 2022:9911167. PMC: 8906956. DOI: 10.1155/2022/9911167. View

Li S, Lei Z, Yang X, Zhao M, Hou Y, Wang D . Propofol Protects Myocardium From Ischemia/Reperfusion Injury by Inhibiting Ferroptosis Through the AKT/p53 Signaling Pathway. Front Pharmacol. 2022; 13:841410. PMC: 8966655. DOI: 10.3389/fphar.2022.841410. View

10.

Shen J, Shen H, Ke L, Chen J, Dang X, Liu B . Knowledge Mapping of Immunotherapy for Hepatocellular Carcinoma: A Bibliometric Study. Front Immunol. 2022; 13:815575. PMC: 8841606. DOI: 10.3389/fimmu.2022.815575. View

11.

Zhao H, Alam A, Pac Soo A, George A, Ma D . Ischemia-Reperfusion Injury Reduces Long Term Renal Graft Survival: Mechanism and Beyond. EBioMedicine. 2018; 28:31-42. PMC: 5835570. DOI: 10.1016/j.ebiom.2018.01.025. View

12.

Urbich M, Globe G, Pantiri K, Heisen M, Bennison C, Wirtz H . A Systematic Review of Medical Costs Associated with Heart Failure in the USA (2014-2020). Pharmacoeconomics. 2020; 38(11):1219-1236. PMC: 7546989. DOI: 10.1007/s40273-020-00952-0. View

13.

Linkermann A, Skouta R, Himmerkus N, Mulay S, Dewitz C, De Zen F . Synchronized renal tubular cell death involves ferroptosis. Proc Natl Acad Sci U S A. 2014; 111(47):16836-41. PMC: 4250130. DOI: 10.1073/pnas.1415518111. View

14.

Fang X, Zhang J, Li Y, Song Y, Yu Y, Cai Z . Malic Enzyme 1 as a Novel Anti-Ferroptotic Regulator in Hepatic Ischemia/Reperfusion Injury. Adv Sci (Weinh). 2023; 10(13):e2205436. PMC: 10161122. DOI: 10.1002/advs.202205436. View

15.

Abassi Z, Armaly Z, Heyman S . Glycocalyx Degradation in Ischemia-Reperfusion Injury. Am J Pathol. 2020; 190(4):752-767. DOI: 10.1016/j.ajpath.2019.08.019. View

16.

Sun X, Ou Z, Chen R, Niu X, Chen D, Kang R . Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology. 2015; 63(1):173-84. PMC: 4688087. DOI: 10.1002/hep.28251. View

17.

Yoshida M, Minagawa S, Araya J, Sakamoto T, Hara H, Tsubouchi K . Involvement of cigarette smoke-induced epithelial cell ferroptosis in COPD pathogenesis. Nat Commun. 2019; 10(1):3145. PMC: 6637122. DOI: 10.1038/s41467-019-10991-7. View

18.

Granata S, Votrico V, Spadaccino F, Catalano V, Netti G, Ranieri E . Oxidative Stress and Ischemia/Reperfusion Injury in Kidney Transplantation: Focus on Ferroptosis, Mitophagy and New Antioxidants. Antioxidants (Basel). 2022; 11(4). PMC: 9024672. DOI: 10.3390/antiox11040769. View

19.

Fernandez A, Sanchez-Tarjuelo R, Cravedi P, Ochando J, Lopez-Hoyos M . Review: Ischemia Reperfusion Injury-A Translational Perspective in Organ Transplantation. Int J Mol Sci. 2020; 21(22). PMC: 7696417. DOI: 10.3390/ijms21228549. View

20.

Wang L, Liu C, Wang L, Tang B . Astragaloside IV mitigates cerebral ischaemia-reperfusion injury via inhibition of P62/Keap1/Nrf2 pathway-mediated ferroptosis. Eur J Pharmacol. 2023; 944:175516. DOI: 10.1016/j.ejphar.2023.175516. View